FrancophonIA/ELRC3.0 huggingface dataset:
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions during) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e)) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja) - vrlo rijetke (manje od 1 tretiranih životinje na 10.000 životinja, uključujući izolirane slučajeve).
English: For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose of Melosus can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
Croatian: U dugotrajnijem liječenju, kad se primijeti klinički odgovor (nakon ≥ 4 dana), dozu Melosusa može se prilagoditi na najnižu individualnu djelotvornu dozu, vodeći računa da stupanj bola i upale povezanih s kroničnim poremećajima mišićno-koštanog sustava može s vremenom varirati.
English: In guinea pigs, an overdose of 0.6 mg/kg body weight administered during 3 days followed by a dose of 0.3 mg/kg during 6 additional days did not cause adverse events typical for meloxicam.
Croatian: U zamorčadi prekoračenje doze od 0,6 mg/kg tjelesne mase primjenjivano tijekom tri dana i popraćeno dozom od 0,3 mg/kg tijekom šest dodatnih dana nije uzrokovalo nuspojave karakteristične za meloksikam.
English: 15 OTHER INFORMATION 5, 10 or 25 ml bottle.
Croatian: 15 OSTALE INFORMACIJE Bočica od 5, 10 ili 25 ml.
English: In very rare cases elevated liver enzymes have been reported.
Croatian: U vrlo rijetkim slučajevima nuspojave su bile povišene vrijednosti jetrenih enzima.
English: Use a standard 1 ml syringe to draw up Melosus according to the bodyweight of the guinea pig.
Croatian: Upotrijebite standardnu štrcaljku od 1 ml za izvlačenje Melosusa u skladu s tjelesnom masom zamorčeta.
English: Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity.
Croatian: Izbjegavati primjenu u dehidriranih, hipovolemičnih ili hipotenzivnih životinja jer postoji potencijalni povećan rizik za razvoj bubrežne toksičnosti.
English: TARGET SPECIES Cats and guinea pigs
Croatian: CILJNE VRSTE ŽIVOTINJA Mačke i zamorčad
English: These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Croatian: Te se nuspojave obično javljaju tijekom prvog tjedna liječenja i u većini slučajeva su prolazne te nestaju nakon prestanka liječenja, ali u vrlo rijetkim slučajevima mogu biti ozbiljne ili smrtonosne.
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Croatian: Posebne mjere opreza koje mora poduzeti osoba koja primjenjuje veterinarsko-medicinskim proizvod na životinjama:
English: PHARMACEUTICAL FORM Oral suspension.
Croatian: OBLIK Peroralna suspenzija.
English: PHARMACEUTICAL FORM Oral suspension
Croatian: OBLIK Peroralna suspenzija
English: For the full list of excipients, see section 6.1.
Croatian: 1,75 mg Potpuni popis pomoćnih tvari vidi u odjeljku 6.1.
English: The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.
Croatian: Međutim, u razdoblju bez liječenja treba uzeti u obzir farmakokinetička svojstva prethodno upotrijebljenih veterinarsko-medicinskih proizvoda.
English: Melosus 0.5 mg/ml oral suspension for cats should not be used following parenteral injection of meloxicam or any other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as appropriate dosage regimens for such follow-up treatments have not been established in cats.
Croatian: Melosus 0,5 mg/ml peroralna suspenzija za mačke ne smije se koristiti nakon parenteralne injekcije meloksikama niti bilo kojeg drugog nesteroidnog protuupalnog lijeka (NSPUL), jer odgovarajući dozni režimi za takve follow-up tretmane nisu još utvrđeni za mačke.
English: People with known hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product.
Croatian: Osobe preosjetljive na nesteroidne protuupalne lijekove (NSPUL) moraju izbjegavati doticaj s ovim veterinarsko-medicinskim proizvodom.
English: Post-operative pain and inflammation following surgical procedures: After initial treatment with meloxicam solution for injection for cats, continue treatment 24 hours later with Melosus 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg body weight.
Croatian: Poslijeoperacijska bol i upala nakon sljedećih kirurških zahvata: Nakon početnog liječenja meloksikam otopiom za injekciju za mačke, liječenje treba nastaviti nakon 24 sata Melosus 0,5 mg/ml peroralnom suspenzijom za mačke u dozi od 0,05 mg meloksikama/kg tjelesne težine.
English: Polyethylene bottle containing 10 ml, 25 ml, 50 ml or 125 ml with a tamper proof child resistant closure and a polypropylene measuring syringe.
Croatian: Polietilenska bočica koja sadrži 10 ml, 25 ml, 50 ml ili 125 ml sa sigurnosnim zatvaračem za zaštitu djece i polipropilenska mjerna štrcaljka.
English: Chronic musculoskeletal disorders in cats: Response to long-term therapy should be monitored at regular intervals by a veterinarian.
Croatian: Kronični mišićno-koštani poremećaji u mačaka: Reakciju na dugotrajnu terapiju treba u pravilnim razmacima nadzirati veterinar.
English: Melosus must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Croatian: Melosus se ne smije primjenjivati zajedno s drugim NSPUL ili glukokortikosteroidima.
English: In very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.
Croatian: U vrlo rijetkim slučajevima nuspojave su bile proljev s primjesama krvi, povraćanje krvi (hematemeza), gastrointestinalna ulceracija i povišene vrijednosti jetrenih enzima.
English: Excipient:
Croatian: Zamorčad:
English: Concurrent administration of potential nephrotoxic veterinary medicinal products should be avoided.
Croatian: Treba izbjegavati istodobnu primjenu potencijalno nefrotoksičnih veterinarsko-medicinskim proizvoda.
English: In case of accidental ingestion, seek medical advice immediately and show this package leaflet or the label to the physician.
Croatian: U slučaju da se nehotice proguta, odmah potražiti pomoć liječnika i pokažite mu ovu uputu o VMP ili etiketu.
English: Shelf-life of the veterinary medicinal product as packaged for sale: 3 years Shelf-life after first opening the immediate packaging: 6 months
Croatian: Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju: 3 godine
English: OTHER INFORMATION 10, 25, 50 or 125 ml bottle.
Croatian: 15. OSTALE INFORMACIJE Bočica od 10, 25, 50 ili 125 ml.
English: Disodium phosphate dodecahydrate Silica, colloidal anhydrous Hydroxyethylcellulose Citric acid monohydrate Sodium cyclamate Sucralose
Croatian: 6.1 Popis pomoćnih tvari natrijev benzoat sorbitol glicerol polisorbat 80 dinatrijev fosfat dodekahidrat silika, koloidna bezvodna hidroksietilceluloza limunska kiselina monohidrat natrijev ciklamat sukroza aroma anisa voda, pročišćena
English: Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent.
Croatian: Ako kliničko poboljšanje nije vidljivo, liječenje treba prekinuti najkasnije nakon 14 dana.
English: Glycerol
Croatian: INDIKACIJAE
English: In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
Croatian: U slučaju da se nehotice proguta, odmah potražiti pomoć liječnika i pokažite mu Uputu o VMP ili etiketu.
English: Alleviation of pain and inflammation in chronic musculo-skeletal disorders in cats.
Croatian: Ublažavanje bolova i upale u kroničnim mišićno-koštanim poremećajima u mačaka.
English: Polyethylene bottle containing 5 ml, 10 ml or 25 ml with a tamper proof child resistant closure and a polypropylene measuring syringe
Croatian: Polietilenska bočica od 5 ml, 10 ml ili 25 ml sa sigurnosnim zatvaračem za zaštitu djece ipolipropilenska mjerna štrcaljka.
English: Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Croatian: Ublažavanje blagih do umjerenih poslijeoperacijskih bolova i upale nakon kirurških zahvata u mačaka, npr. ortopedski zahvat ili zahvat na mekom tkivu.
English: Dose of 0.2 mg meloxicam/kg body weight: 0.4 ml/kg body weight Dose of 0.1 mg meloxicam/kg body weight: 0.2 ml/kg body weight
Croatian: Doziranje 0,2 mg meloksikama/kg tjelesne mase: 0,4 ml/kg tjelesne mase.
English: Do not use the cat syringe with the kg-body weight scale for guinea pigs.
Croatian: Za zamorčad nemojte upotrebljavati štrcaljku za mačke s ljestvicom mjernih oznaka za tjelesnu težinu u kg.
English: People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product.
Croatian: Osobe preosjetljive na NSPUL moraju izbjegavati doticaj s ovim veterinarsko-medicinskim proizvodom.
English: Meloxicam 0.5 mg
Croatian: Meloksikam 0,5 mg
English: In cats, Melosus 0.5 mg/ml oral suspension for cats should be used.
Croatian: U mačaka treba primijeniti Melosus 0,5 mg/ml peroralnu suspenziju za mačke.
English: INDICATION(S) Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Croatian: Ublažavanje upale i bolova u akutnim i kroničnim mišićno-koštanim poremećajima u pasa.
English: Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.05 mg meloxicam/kg body weight.
Croatian: Liječenje treba nastaviti jedanput na dan (u razmacima od 24 sata) peroralnom primjenom doze održavanja od 0,05 mg meloksikama/kg tjelesne težine.
English: Meloxicam 1.5 mg
Croatian: Meloksikam 1,5 mg
English: The suspension can be given using the measuring syringe provided in the package.
Croatian: Suspenzija se može upotrijebiti pomoću mjerne štrcaljke priložene u pakovanju.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER CP-Pharma Handelsgesellschaft mbH, Germany
Croatian: 15. NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE U PROMET CP-Pharma Handelsgesellschaft mbH
English: Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
Croatian: Ako kliničko poboljšanje nije vidljivo, liječenje treba prekinuti nakon 10 dana.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/10/116/003 125 ml
Croatian: 16. BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET EU/2/10/116/003 125 ml
English: In cats, typical adverse reactions of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported.
Croatian: U mačaka su povremeno zabilježene nuspojave karakteristične za nesteroidne protuupalne lijekove (NSPUL) poput gubitka apetita, povraćanja, proljeva, okultnog krvarenja u izmetu, apatija i zatajenja bubrega.
English: Active substance: Meloxicam 0.5 mg/ml
Croatian: Djelatna tvar: Meloksikam 0,5 mg/ml
English: The suspension can be given using the Melosus measuring syringe provided in the package.
Croatian: Način i put primjene Suspenzija se može dati pomoću Melosus mjerne štrcaljke priložene u pakovanju.
English: Marketing authorisation holder: CP-Pharma Handelsgesellschaft mbH Ostlandring 13
Croatian: Nositelj odobrenja za stavljanje u promet: CP-Pharma Handelsgesellschaft mbH Ostlandring 13
English: Post-operative use in cats and guinea pigs: In case additional pain relief is required, multimodal pain therapy should be considered.
Croatian: U slučaju da je potrebno dodatno ublažavanje bolova, treba razmotriti mogućnost multimodalne terapije boli.
English: ROUTE OF ADMINISTRATION Oral use.
Croatian: PUT(EVI) PRIMJENE Peroralna primjena.
English: Typical adverse reactions of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported.
Croatian: Povremeno su zabilježene nuspojave karakteristične za nesteroidne protuupalne lijekove (NSPUL) poput gubitka apetita, povraćanja, proljeva, okultnog krvarenja u izmetu, apatija i zatajenja bubrega.
English: MARKETING AUTHORISATION NUMBERS EU/2/10/116/007 5 ml
Croatian: 16. BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET EU/2/10/116/007 5 ml
English: MARKETING AUTHORISATION HOLDER CP-Pharma Handelsgesellschaft mbH Ostlandring 13
Croatian: Nositelj odobrenja za stavljanje u promet CP-Pharma Handelsgesellschaft mbH Ostlandring 13
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) Meloxicam 0.5 mg/ml
Croatian: KOLIČINA DJELATNE(IH) TVARI Meloksikam 0,5 mg/ml
English: PACKAGE LEAFLET: Melosus 1.5 mg/ml oral suspension for dogs
Croatian: UPUTA O VMP: Melosus 1,5 mg/ml peroralna suspenzija za pse
English: Excipients: Sodium benzoate 1.75 mg/ml
Croatian: Pomoćne tvari: Natrijev benzoat: 1,75 mg/ml
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) Meloxicam 1.5 mg/ml
Croatian: KOLIČINA DJELATNE(IH) TVARI Meloksikam 1,5 mg/ml
English: Sodium benzoate 1.75 mg
Croatian: Natrijev benzoat: 1,75 mg/ml
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Melosus 1.5 mg/ml oral suspension for dogs
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Melosus 1,5 mg/ml peroralna suspenzija za pse
English: PACKAGE LEAFLET: Melosus 0.5 mg/ml oral suspension for cats and guinea pigs
Croatian: UPUTA O VMP ZA: Melosus 0,5 mg/ml peroralna suspenzija za mačke i zamorčad
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Melosus 1.5 mg/ml oral suspension for dogs Meloxicam
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Melosus 1,5 mg/ml peroralna suspenzija za pse Meloksikam
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Melosus 1.5 mg/ml oral suspension for dogs meloxicam
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Melosus 1,5 mg/ml peroralna suspenzija za pse meloksikam
English: Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day.
Croatian: Početak liječenja čini jednokratna doza od 0,2 mg meloksikama/kg tjelesne težine primijenjena prvog dana.
English: Name and address of the manufacturer responsible for batch release
Croatian: Naziv i adresa proizvođača odgovornog za puštanje serije u promet Produlab Pharma B.V.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Melosus 0.5 mg/ml oral suspension for cats and guinea pigs
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Melosus 0,5 mg/ml peroralna suspenzija za mačke i zamorčad
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Melosus 0.5 mg/ml oral suspension for cats and guinea pigs Meloxicam
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Melosus 0,5 mg/ml peroralna suspenzija za mačke i zamorčad Meloksikam
English: Initial treatment is a single oral dose of 0.1 mg meloxicam/kg body weight on the first day.
Croatian: Početak liječenja čini jednokratna peroralna doza od 0,1 mg meloksikama/kg tjelesne težine primijenjena prvog dana.
English: No special precautions are required.
Croatian: Nisu potrebne posebne mjere opreza.
English: Signs can include fever, depression, coughing, sneezing, difficulty breathing and loss of appetite.
Croatian: Znakovi mogu uključivati vrućicu, depresiju, kašalj, kihanje, otežano disanje i gubitak apetita.
English: Porcine influenza vaccine (inactivated)
Croatian: Cjepivo protiv svinjske influence (inaktivirano)
English: It is given as two injections into the muscle three weeks apart.
Croatian: Primjenjuje se kao dvije injekcije u mišić u razmaku od tri tjedna.
English: In case of accidental self-injection only a minor injection site reaction is expected.
Croatian: U slučaju nehotičnog samoinjektiranja očekuje se samo manja reakcija na mjestu primjene injekcije.
English: The vaccine starts to be effective one week after the second injection and protection lasts for three months.
Croatian: Cjepivo postaje učinkovito tjedan dana nakon druge injekcije, a zaštita traje tri mjeseca.
English: This active immune response will help to protect the pig against the disease caused by this virus.
Croatian: Takav aktivni imunosni odgovor pomoći će u zaštiti svinje od bolesti prouzročene ovim virusom.
English: When a pig is given the vaccine the pig's immune system recognises the virus as ‘foreign' and reacts by building up an active immune response.
Croatian: Kada svinja primi cjepivo, imunosni sustav svinje prepozna virus kao „strano tijelo” i reagira izgradnjom aktivnog imunosnog odgovora.
English: The full EPAR for Respiporc FLUpan H1N1 can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za VMP Respiporc FLUpan H1N1 nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: This summary was last updated in March 2017.
Croatian: Ovaj sažetak je posljednji put ažuriran u 03-2017.
English: The effectiveness of Respiporc FLUpan H1N1 was shown in three laboratory studies and one combined field/laboratory study.
Croatian: Djelotvornost VMP-a Respiporc FLUpan H1N1 dokazana je u trima laboratorijskim ispitivanjima i jednom kombiniranom terenskom/laboratorijskom ispitivanju.
English: The most common side effects with Respiporc FLUpan H1N1 (which may affect up to 1 in 10 animals) are a short-lived increase in rectal temperature, not exceeding 2 °C, which does not last for more than one day and a transient swelling up to 2 cm3 at the site of injection which usually resolves within
Croatian: Najčešće nuspojave kod primjene VMP-a Respiporc FLUpan H1N1 (mogu zahvatiti do 1 na 10 životinja) su kratkotrajna povišenja rektalne temperature koja ne prelaze 2 °C i ne traju dulje od jednog dana, te prolazna oticanja na mjestu primjene injekcije veličine do 2 cm3, što obično nestaje unutar 5 dana.
English: Respiporc FLUpan H1N1 is a vaccine used to protect pigs from eight weeks of age against swine influenza caused by pandemic subtype H1N1.
Croatian: Respiporc FLUpan H1N1 je cjepivo koje se primjenjuje za zaštitu svinja starijih od osam tjedana od gripe uzrokovane pandemijskim podtipom virusa H1N1.
English: The vaccine contains inactivated (killed) influenza A virus/Jena/VI5258/2009(H1N1)pdm09, a strain of the virus that causes swine influenza.
Croatian: Cjepivo sadrži inaktivirani (mrtav) virus influence tipa A, virus/Jena/VI5258/2009(H1N1)pdm09, soj virusa koji izaziva svinjsku gripu.
English: Swine influenza or swine flu is a disease of the lungs and airways in pigs.
Croatian: Svinjska influenca ili svinjska gripa bolest je pluća i dišnih putova svinje.
English: It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use.
Croatian: Objašnjava kako je Agencija ocijenila VMP da bi preporučila njegovo odobrenje u EU-u te uvjete za njegovu primjenu.
English: The withdrawal period for meat from pigs treated with Respiporc FLUpan H1N1 is ‘zero' days, which means there is no mandatory waiting time.
Croatian: Razdoblje karencije za meso svinja liječenih VMP-om Respiporc FLUpan H1N1 iznosi „nula” dana, drugim riječima, nema obveznog razdoblja čekanja.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Respiporc FLUpan H1N1's benefits are greater than its risks and recommended that it be approved for use in the EU.
Croatian: Odbor za veterinarsko-medicinske proizvode (CVMP) pri Agenciji odlučio je da koristi od VMP Respiporc FLUpan H1N1 nadmašuju s njim povezane rizike te je preporučio njegovo odobrenje za primjenu u Europskoj uniji.
English: The studies showed that pigs vaccinated with Respiporc FLUpan H1N1 had a reduction of virus in the lung and excreted from the nose.
Croatian: Ispitivanja su pokazala da se u svinja cijepljenih VMP-om Respiporc FLUpan H1N1 smanjila količina virusa u plućima i iscjetku iz nosa.
English: Respiporc FLUpan H1N1 contains an adjuvant (carbomer) to enhance the immune response.
Croatian: Respiporc FLUpan H1N1 sadrži adjuvans (karbomer) radi pojačavanja imunosnog odgovora.
English: The European Commission granted a marketing authorisation valid throughout the EU for Respiporc FLUpan H1N1 on 17 May 2017.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje je za VMP Respiporc FLUpan H1N1 na snazi u Europskoj uniji od 17/05/2017.
English: virus (Pan H1N1) which has been inactivated so it cannot cause the disease.
Croatian: inaktiviran tako da ne može prouzročiti bolest.
English: Respiporc FLUpan H1N1 is available as a suspension for injection and can only be obtained with a prescription.
Croatian: Respiporc FLUpan H1N1 dostupan je kao suspenzija za injekciju i izdaje se samo na veterinarski recept.
English: This is a summary of the European public assessment report (EPAR) for Respiporc FLUpan H1N1.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) veterinarsko-medicinskog proizvoda Respiporc FLUpan H1N1.
English: It is not intended to provide practical advice on how to use Respiporc FLUpan H1N1.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni VMP-a Respiporc FLUpan H1N1.
English: For practical information about using Respiporc FLUpan H1N1, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Croatian: Praktične informacije o primjeni VMP-a Respiporc FLUpan H1N1 vlasnici životinja ili uzgajivači trebaju pročitati u uputi o VMP, odnosno obratiti se svom veterinaru ili ljekarniku.
English: For more information about treatment with Respiporc FLUpan H1N1, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Croatian: Dodatne informacije o terapiji VMP-om Respiporc FLUpan H1N1 vlasnici životinja ili uzgajivači trebaju pročitati u uputi o VMP-u, odnosno obratiti se svom veterinaru ili ljekarniku.
English: What is Respiporc FLUpan H1N1 and what is it used for?
Croatian: Što je Respiporc FLUpan H1N1 i za što se koristi?
English: Other information about Respiporc FLUpan H1N1:
Croatian: Ostale informacije o VMP-u Respiporc FLUpan H1N1:
English: Respiporc FLUpan H1N1 is a vaccine.
Croatian: Respiporc FLUpan H1N1 je cjepivo.
English: What are the risks associated with Respiporc FLUpan H1N1?
Croatian: Koji su rizici povezani s VMP-om Respiporc FLUpan H1N1?
English: Why is Respiporc FLUpan H1N1 approved?
Croatian: Zašto je Respiporc FLUpan H1N1 odobren?
English: How is Respiporc FLUpan H1N1 used?
Croatian: Kako se Respiporc FLUpan H1N1 koristi?
English: How does Respiporc FLUpan H1N1 work?
Croatian: Kako djeluje Respiporc FLUpan H1N1?
English: Respiporc FLUpan H1N1 contains influenza A
Croatian: Respiporc FLUpan H1N1 sadrži virus influence tipa A (Pan H1N1) koji je
English: What benefits of Respiporc FLUpan H1N1 have been shown in studies?
Croatian: Koje su koristi VMP-a Respiporc FLUpan H1N1 utvrđene u ispitivanjima?
English: You may then hear or feel a click.
Croatian: Možda ćete tada čuti ili osjetiti ‘klik'.
English: The signs of a serious allergic reaction are:
Croatian: Znakovi ozbiljne alergijske reakcije su:
English: Ryzodeg with alcohol
Croatian: Ryzodeg s alkoholom
English: What Ryzodeg is and what it is used for
Croatian: Što je Ryzodeg i za što se koristi
English: • the local reactions spread to other parts of your body
Croatian: • širenje lokalnih reakcija na druge dijelove Vašeg tijela
English: There were no statistically significant differences between the two treatment groups.
Croatian: Nije bilo statistički značajnih razlika između tih dviju liječenih skupina.